The Valley Desk

NCT02733042 · Interventional trial

A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia

Overall registry status Completed

Phase 1 · Phase 2

Conditions Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov